Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v7-EN
Language French English
Date Updated 2018-07-05 2018-07-03
Drug Identification Number 02347296 02347296
Brand name MYLAN-IRBESARTAN MYLAN-IRBESARTAN
Common or Proper name IRBESARTAN IRBESARTAN
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients IRBESARTAN IRBESARTAN
Strength(s) 75MG 75MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 90 90
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-07-03 2018-07-03
Actual start date 2018-07-03
Estimated end date Unknown Unknown
Actual end date 2018-07-03 2018-07-03
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments discontinued in ID 44870 discontinued in ID 44870
Health Canada comments